{"title":"Randomised Trial of Pharmacist Integration in Haemodialysis Teams: Effects on Phosphorus Control and Patient Outcomes.","authors":"Xin Jiang, Xiaolan Ye, Haihong Lin, Junfen Guo, Yaoqin Huang, Zhenzhen Lin, Liangliang Xu, Xuefeng Li, Chen Chen, Linying Kong, Cheng Jiang","doi":"10.1159/000545475","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Despite the limited historical engagement of hospital pharmacists in managing blood phosphorus levels, their involvement in this aspect of care for hemodialysis patients remains an underexplored yet potentially promising and effective approach that warrants further investigation.</p><p><strong>Methods: </strong>A prospective, randomized controlled clinical trial was conducted to compare a control group receiving standard care from doctors and nurses with a test group that, in addition to standard care, received medication education and health promotion interventions from pharmacists. This trial is registered at chictr.org.cn, ChiCTR2100044887 and is complete.</p><p><strong>Results: </strong>The test group demonstrated a significant reduction in blood phosphorus levels (P = 0.0056) and an improvement in blood calcium levels (P = 0.0238), whereas the control group showed no significant changes. The study also identified several potential high-risk factors for chronic kidney disease, including rural residence (72% of the patients), hypertension (84%), low educational attainment (84%), occupation as farmers or laborers (92%), and low to middle income levels (52%). Conversely, factors such as smoking, alcohol consumption, and marital status were not found to be significant risk factors. The impact of varying health promotion methodologies on biochemical indicators and blood pressure was minimal.</p><p><strong>Conclusions: </strong>The integration of pharmacists into the clinical team appeared to contribute to the reduction of blood phosphorus levels and healthcare expenditures, highlighting their pivotal role in the cost-effective, multidisciplinary management of hemodialysis patients. This finding underscores the significant economic and clinical importance of considering pharmacists as valuable members of the healthcare team in efforts to optimize patient outcomes.</p>","PeriodicalId":8953,"journal":{"name":"Blood Purification","volume":" ","pages":"1-20"},"PeriodicalIF":2.2000,"publicationDate":"2025-04-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Blood Purification","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1159/000545475","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"HEMATOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Despite the limited historical engagement of hospital pharmacists in managing blood phosphorus levels, their involvement in this aspect of care for hemodialysis patients remains an underexplored yet potentially promising and effective approach that warrants further investigation.
Methods: A prospective, randomized controlled clinical trial was conducted to compare a control group receiving standard care from doctors and nurses with a test group that, in addition to standard care, received medication education and health promotion interventions from pharmacists. This trial is registered at chictr.org.cn, ChiCTR2100044887 and is complete.
Results: The test group demonstrated a significant reduction in blood phosphorus levels (P = 0.0056) and an improvement in blood calcium levels (P = 0.0238), whereas the control group showed no significant changes. The study also identified several potential high-risk factors for chronic kidney disease, including rural residence (72% of the patients), hypertension (84%), low educational attainment (84%), occupation as farmers or laborers (92%), and low to middle income levels (52%). Conversely, factors such as smoking, alcohol consumption, and marital status were not found to be significant risk factors. The impact of varying health promotion methodologies on biochemical indicators and blood pressure was minimal.
Conclusions: The integration of pharmacists into the clinical team appeared to contribute to the reduction of blood phosphorus levels and healthcare expenditures, highlighting their pivotal role in the cost-effective, multidisciplinary management of hemodialysis patients. This finding underscores the significant economic and clinical importance of considering pharmacists as valuable members of the healthcare team in efforts to optimize patient outcomes.
期刊介绍：
Practical information on hemodialysis, hemofiltration, peritoneal dialysis and apheresis is featured in this journal. Recognizing the critical importance of equipment and procedures, particular emphasis has been placed on reports, drawn from a wide range of fields, describing technical advances and improvements in methodology. Papers reflect the search for cost-effective solutions which increase not only patient survival but also patient comfort and disease improvement through prevention or correction of undesirable effects. Advances in vascular access and blood anticoagulation, problems associated with exposure of blood to foreign surfaces and acute-care nephrology, including continuous therapies, also receive attention. Nephrologists, internists, intensivists and hospital staff involved in dialysis, apheresis and immunoadsorption for acute and chronic solid organ failure will find this journal useful and informative. ''Blood Purification'' also serves as a platform for multidisciplinary experiences involving nephrologists, cardiologists and critical care physicians in order to expand the level of interaction between different disciplines and specialities.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
